Investment Success in Public Health: An Analysis of the Cost-Effectiveness and Cost-Benefit of the Global Programme to Eliminate Lymphatic Filariasis

BACKGROUND. It has been estimated that $154 million per year will be required during 2015–2020 to continue the Global Programme to Eliminate Lymphatic Filariasis (GPELF). In light of this, it is important to understand the program’s current value. Here, we evaluate the cost-effectiveness and cost-be...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Turner, Hugo C., Bettis, Alison A., Chu, Brian K., McFarland, Deborah A., Hooper, Pamela J., Mante, Sunny D., Fitzpatrick, Christopher, Bradley, Mark H.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Major Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5404931/
https://ncbi.nlm.nih.gov/pubmed/27956460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciw835
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados